Oscar Kashala

1.1k total citations
27 papers, 866 citations indexed

About

Oscar Kashala is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Oscar Kashala has authored 27 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Oscar Kashala's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Oscar Kashala is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Oscar Kashala collaborates with scholars based in United States, Switzerland and Colombia. Oscar Kashala's co-authors include Juanita Garrison, Kenneth A. Foon, Malaya Bhattacharya‐Chatterjee, April Teitelbaum, Mala Chakraborty, Ralph A. Reisfeld, Laura Hutchins, William J. John, Sunil K. Chatterjee and Claudia Daubenberger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Oscar Kashala

27 papers receiving 846 citations

Peers

Countries citing papers authored by Oscar Kashala

Since Specialization

Citations

This map shows the geographic impact of Oscar Kashala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar Kashala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar Kashala more than expected).

Fields of papers citing papers by Oscar Kashala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar Kashala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar Kashala. The network helps show where Oscar Kashala may publish in the future.

Co-authorship network of co-authors of Oscar Kashala

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar Kashala. A scholar is included among the top collaborators of Oscar Kashala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar Kashala. Oscar Kashala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma 2016 ·Blood ·Thorsten Gantke, Michael Weichel, Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Remko A. Griep, (unknown), Oscar Kashala, Martin Treder	8
2	Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma 2009 ·Journal of Translational Medicine ·Antoni Ribas, John M. Kirkwood, Michael B. Atkins, Theresa L. Whiteside, William E. Gooding, Andreas Kovar, Stephen D. Gillies, Oscar Kashala, Michael A. Morse	36
3	A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors 2006 ·Cancer ·David P. Ryan, Bert H. O’Neil, Jeffrey G. Supko, (unknown), Elizabeth Claire Dees, Leonard J. Appleman, Jeffrey W. Clark, (unknown), Robert Z. Orlowski, Oscar Kashala, Joseph P. Eder, James C. Cusack	48
4	Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial 2006 ·Journal of Thoracic Oncology ·Primo N. Lara, (unknown), David I. Quinn, Heinz Josef Lenz, Angela M. Davies, Derick Lau, Paul H. Gumerlock, Jeff Longmate, James H. Doroshow, David P. Schenkein, Oscar Kashala, David R. Gandara	26
5	Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors 2006 ·Cancer ·David P. Ryan, Leonard J. Appleman, Thomas J. Lynch, Jeffrey G. Supko, P. Fidias, Jeffrey W. Clark, Mayer Fishman, Andrew X. Zhu, Peter C. Enzinger, Oscar Kashala, James C. Cusack, Joseph P. Eder	39
6	Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial 2006 ·Journal of Thoracic Oncology ·Primo N. Lara, (unknown), David I. Quinn, Heinz Josef Lenz, Angela M. Davies, Derick Lau, Paul H. Gumerlock, Jeff Longmate, James H. Doroshow, David P. Schenkein, Oscar Kashala, David R. Gandara	17
7	O-084 Phase 2 study of bortezomib±docetaxel in advanced non-smallcell lung cancer (NSCLC) 2005 ·Lung Cancer ·(unknown), Frank V. Fossella, Panos Fidias, (unknown), Robert J. Belt, Ramaswamy Govindan, Luis E. Raez, Joan H. Schiller, Oscar Kashala, Karen Kelly	1
8	Pharmacogenomics 2004 ·Advances in Anatomic Pathology ·Jeffrey S. Ross, David P. Schenkein, Oscar Kashala, Gerald P. Linette, James Stec, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi	21
9	Phase (ph) 2 study of bortezomib ± docetaxel in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC): Preliminary results 2004 ·Journal of Clinical Oncology ·(unknown), Robert J. Belt, Frank V. Fossella, Ronald B. Natale, Francisco Robert, Panos Fidias, Kathleen Kelly, Oscar Kashala, David P. Schenkein, Joan H. Schiller	18
10	Bortezomib ± irinotecan in relapsed/refractory colorectal cancer (CRC): Interim analysis results from phase (ph) 2b study 2004 ·Journal of Clinical Oncology ·Tomislav Dragovich, Heinz‐Josef Lenz, Caio Max S. Rocha Lima, Peter Kozuch, H. S. Hochster, Bert H. O’Neil, Omar Atiq, J. Marc Pipas, Oscar Kashala, David P. Schenkein	4
11	Phase (ph) 2 study of bortezomib ± docetaxel in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC): Preliminary results 2004 ·Journal of Clinical Oncology ·(unknown), Robert J. Belt, Frank V. Fossella, Ronald B. Natale, Francisco Robert, Panos Fidias, Kathleen Kelly, Oscar Kashala, David P. Schenkein, Joan H. Schiller	7
12	Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 2002 ·Vaccine ·Oscar Kashala, Roberto Amador, María V Valero-Bernal, Alberto Moreno, Arnoldo Barbosa, Beatrice Nickel, Claudia Daubenberger, Fanny Guzmán, Gerd Pluschke, Manuel E. Patarroyo	71
13	Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites 2002 ·Vaccine ·Robert Edelman, Steven S. Wasserman, James G. Kublin, Sacared A Bodison, Elizabeth Nardin, Giane A. Oliveira, (unknown), Carter L. Diggs, Oscar Kashala, Barbara J. Schmeckpeper, Robert G. Hamilton	20
14	Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope ofPlasmodium falciparum merozoite surface protein?1 displaying dimorphic amino acid polymorphism are highly constrained 2002 ·European Journal of Immunology ·Claudia Daubenberger, Beatrice Nickel, Carlo Ciatto, (unknown), (unknown), Laura Rossi, Uwe Siegler, John A. Robinson, Oscar Kashala, Manuel E. Patarroyo, Gerd Pluschke	17
15	Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A 2001 ·Molecular and Biochemical Parasitology ·Christian F. Ockenhouse, Arnoldo Barbosa, Douglas P. Blackall, Cheryl I. Murphy, Oscar Kashala, Sheetij Dutta, David E. Lanar, Jon R. Daugherty	22
16	Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen 1999 ·Journal of Clinical Oncology ·Kenneth A. Foon, William J. John, Mala Chakraborty, (unknown), April Teitelbaum, Juanita Garrison, Oscar Kashala, Sunil K. Chatterjee, Malaya Bhattacharya‐Chatterjee	123
17	Hepatitis B Virus Activation among Central Africans Infected with Human Immunodeficiency Virus (HIV) Type 1: Pre-s2 Antigen Is Predominantly Expressed in HIV Infection 1994 ·The Journal of Infectious Diseases ·Oscar Kashala, (unknown), Patrick Kayembé, (unknown), Max Essex	18
18	Infection with Human Immunodeficiency Virus Type I (HIV-1) and Human T Cell Lymphotropic Viruses among Leprosy Patients and Contacts: Correlation between HIV-1 Cross-Reactivity and Antibodies to Lipoarabinomannan 1994 ·The Journal of Infectious Diseases ·Oscar Kashala, Richard Marlink, Médard Ilunga, (unknown), (unknown), Ke Xu, (unknown), (unknown), Max Essex	35
19	Humoral Aspects of Anti-HIV Immune Responses in Zairians with AIDS: Lower Antigenemia Does Not Correlate with Immune Complex Levels 1993 ·AIDS Research and Human Retroviruses ·Oscar Kashala, Patrick Kayembé, Phyllis Kanki, (unknown), (unknown), (unknown), (unknown), Max Essex	5
20	Isotypic Distribution of HIV-1-Specific Antibodies in Individuals from Central Africa 1992 ·Viral Immunology ·Magdalena Kovacsovics-Bankowski, Claudio Carini, Oscar Kashala, Max Essex	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact